Table 3.
Screening responses
Diabetes (n = 50) | Inflammatory bowel disease (n = 32) | Cystic fibrosis (n = 27) | Total (N = 109) | |
---|---|---|---|---|
PHQ-9 | ||||
PHQ-9, mean ± SDa,b | 4.6 ± 5.0 | 6.0 ± 5.3 | 2.2 ± 3.2 | 4.4 ± 4.9 |
PHQ-9 ≥ 11, n (%)c | 7 (14) | 4 (13) | 2 (7) | 13 (12) |
PHQ-9 item 9 > 0, n (%)c | 3 (6) | 5 (16) | 1 (4) | 9 (8) |
Positive screens, n (%)c | 8 (16) | 5 (16) | 3 (11) | 16 (15) |
PGH-7 | ||||
PGH-7, mean ± SDc | 26.0 ± 5.1 | 23.9 ± 5.7 | 26.4 ± 3.6 | 25.5 ± 5.0 |
Past-year history of mental health services | ||||
Yes, n (%)c | 6 (12) | 9 (28) | — | — |
Yes among those with positive screens on PHQ-9, n (% of positive screens)c | 3 (38) | 3 (60) | — | — |
PGH-7 = 7-item PROMIS Pediatric Global Health Scale; PHQ-9 = 9-item Patient Health Questionnaire; SD = standard deviation.
Significant difference between diabetes and CF (p < .05).
Significant difference between IBD and CF (p < .05).
No significant differences among groups.